Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doran

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Journal of the American Society of Nephrology : JASN|June 29, 2002
Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrologyMatthias Kretzler, Clemens D Cohen, Peter Doran, et al.
Research Involvement and Engagement|May 19, 2021
Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conferenceEleanor Coleman, Lydia O'Sullivan, Rachel Crowley, et al.
Trials|September 5, 2020
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trialAoife Cotter, Deborah Wallace, Cormac McCarthy, et al.
BMJ Open Gastroenterology|January 31, 2018
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)Juliette Sheridan, Carol Ann Coe, Peter Doran, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2021
Urinary biomarkers predict progression and adverse outcomes of acute kidney injury in critical illnessStephen Duff, Ruairi Irwin, Jean Maxime Cote, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 28, 2009
Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapiesJulio Gallego-Delgado, Susan B Connolly, Alberto Lázaro, et al.
Age and Ageing|February 27, 2023
Building resilience and reversing frailty: a randomised controlled trial of a primary care intervention for older adultsJohn Travers, Roman Romero-Ortuno, John Langan, et al.
American Journal of Nephrology|June 17, 2019
Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation StudyBlaithin A McMahon, Marie Galligan, Lynn Redahan, et al.
The Journal of Biological Chemistry|March 23, 2004
Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathyDenise M Sadlier, Susan B Connolly, Niamh E Kieran, et al.
Kidney International|December 1, 2005
Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritisDenise M Sadlier, Xuesong Ouyang, Blaithin McMahon, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Journal of the American Society of Nephrology : JASN|June 29, 2002
Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrologyMatthias Kretzler, Clemens D Cohen, Peter Doran, et al.
Research Involvement and Engagement|May 19, 2021
Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conferenceEleanor Coleman, Lydia O'Sullivan, Rachel Crowley, et al.
Trials|September 5, 2020
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trialAoife Cotter, Deborah Wallace, Cormac McCarthy, et al.
BMJ Open Gastroenterology|January 31, 2018
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)Juliette Sheridan, Carol Ann Coe, Peter Doran, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2021
Urinary biomarkers predict progression and adverse outcomes of acute kidney injury in critical illnessStephen Duff, Ruairi Irwin, Jean Maxime Cote, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 28, 2009
Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapiesJulio Gallego-Delgado, Susan B Connolly, Alberto Lázaro, et al.
Age and Ageing|February 27, 2023
Building resilience and reversing frailty: a randomised controlled trial of a primary care intervention for older adultsJohn Travers, Roman Romero-Ortuno, John Langan, et al.
American Journal of Nephrology|June 17, 2019
Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation StudyBlaithin A McMahon, Marie Galligan, Lynn Redahan, et al.
The Journal of Biological Chemistry|March 23, 2004
Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathyDenise M Sadlier, Susan B Connolly, Niamh E Kieran, et al.
Kidney International|December 1, 2005
Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritisDenise M Sadlier, Xuesong Ouyang, Blaithin McMahon, et al.
Pageof 8